Initial Results of National Institutes of Health (NIH) Funded Study Reveal Glucosamine and Chondroitin Effective in Treating Moderate to Severe Osteoarthritis Knee Pain.

Findings Bring New Hope for Millions of Americans Suffering from Arthritis For 21 million Americans hobbled by osteoarthritis, new science confirms nutritional supplements glucosamine and chondroitin are the right combination for effective knee pain relief. The Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), funded by NIH, rigorously evaluated the efficacy and safety of glucosamine and chondroitin in 1,258 people, concluding in its abstract that the "combination of glucosamine and chondroitin sulfate is effective in treating moderate to severe knee pain due to osteoarthritis."

GAIT lead researcher Daniel O. Clegg, M.D., Professor of Medicine and Chief of Rheumatology at the University of Utah, will present findings from the full study on November 14, 2005 at the American College of Rheumatology's Scientific Meeting in San Diego, California.

"GAIT brings good news to adults suffering from the wear and tear of cartilage degeneration, particularly those who cannot tolerate the side effects of taking nonsteroidal anti-inflammatory drugs (NSAIDs)," said C. Thomas Vangsness, Jr., MD, Professor Orthopaedic Surgery, Keck School of Medicine, University of Southern California. "For years glucosamine and chondroitin have been well recognized alternative solutions to pharmaceutical options in treating osteoarthritis patients in Europe, Asia and Russia. In fact, preliminary results reported in the GAIT abstract indicated glucosamine and chondroitin were found to be more effective than Celebrex